Stockscreener 앱 받기
11.80
0.08%
0.01
시간 외 거래:
11.79
-0.01
-0.08%
전일 마감가:
$11.79
열려 있는:
$11.67
하루 거래량:
256.33K
Relative Volume:
0.63
시가총액:
$476.98M
수익:
$825.37M
순이익/손실:
$-60.01M
주가수익비율:
-7.8557
EPS:
-1.5021
순현금흐름:
$-4.46M
1주 성능:
+4.89%
1개월 성능:
+29.10%
6개월 성능:
-10.81%
1년 성능:
+6.88%
1일 변동 폭
$11.41
$11.90
1주일 범위
$11.32
$12.58
52주 변동 폭
$8.85
$16.99
Orthofix Medical Inc Stock (OFIX) Company Profile
명칭
Orthofix Medical Inc
전화
214-937-2000
주소
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
11.80 | 481.02M | 825.37M | -60.01M | -4.46M | -1.5021 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | TD Cowen | Hold |
| 2025-10-28 | 재개 | Stifel | Buy |
| 2025-01-22 | 개시 | Canaccord Genuity | Buy |
| 2024-11-08 | 업그레이드 | Stifel | Hold → Buy |
| 2024-05-08 | 업그레이드 | ROTH MKM | Neutral → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-09-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-09-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-07-19 | 재개 | BTIG Research | Buy |
| 2022-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2020-10-20 | 개시 | Stifel | Hold |
| 2019-10-29 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-06-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-06-14 | 개시 | Ladenburg Thalmann | Buy |
| 2017-05-23 | 개시 | SunTrust | Buy |
| 2015-07-10 | 개시 | Sidoti | Buy |
| 2013-05-09 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2013-01-08 | 재확인 | Mizuho | Buy |
| 2010-06-21 | 개시 | Boenning & Scattergood | Outperform |
| 2010-03-09 | 재확인 | Jefferies & Co | Buy |
| 2010-02-18 | 업그레이드 | Susquehanna Financial | Neutral → Positive |
| 2010-01-22 | 개시 | Jefferies & Co | Buy |
| 2009-11-03 | 업그레이드 | Wells Fargo | Underperform → Market Perform |
| 2009-07-31 | 재확인 | Jefferies & Co | Buy |
| 2009-07-31 | 업그레이드 | Thomas Weisel | Market Weight → Overweight |
| 2009-05-26 | 재확인 | Jefferies & Co | Buy |
| 2009-04-17 | 다운그레이드 | Wachovia | Mkt Perform → Underperform |
| 2009-02-19 | 개시 | Canaccord Adams | Buy |
| 2008-07-07 | 다운그레이드 | Wachovia | Outperform → Mkt Perform |
모두보기
Orthofix Medical Inc 주식(OFIX)의 최신 뉴스
Can Orthofix Medical (NASDAQ:OFIX) Capitalize on A Key Medicare Shift? - Kalkine Media
OFIX|Orthofix Medical Inc|Price:11.885|Chg%:+0.635 - TradingKey
Orthofix Medical Inc (OFIX) Cash Flow - TradingKey
Orthofix Medical Inc (OFIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Orthofix Medical Inc (OFIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Orthofix Medical Inc (OFIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OFIX|Orthofix Medical Inc|Price:11.715|Chg%:+0.465 - TradingKey
OFIX|Orthofix Medical Inc|Price:11.460|Chg%:+0.210 - TradingKey
Orthofix Medical Inc. (OFIX) stock price, news, quote and history - Yahoo Finance UK
Orthofix Medical Inc (OFIX) Institutional Confidence - TradingKey
Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement - Yahoo Finance
Wall Street Analysts Think Orthofix (OFIX) Could Surge 33.28%: Read This Before Placing a Bet - Yahoo Finance Singapore
Hospitals Get Live Surgical Case Views With Canopus Command - Stock Titan
MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth - Sahm
Orthofix to Participate in Upcoming Investor Conferences - Business Wire
Press Release: Orthofix to Report Second Quarter 2026 Financial Results - Moomoo
Orthofix to Report Second Quarter 2026 Financial Results - Business Wire
Orthofix surges after CMS change on non-invasive bone growth stimulators - MSN
Price to sales forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Orthofix Medical (OFIX) Gets a Buy from Canaccord Genuity - The Globe and Mail
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Orthofix Medical (OFIX) Dips 1.54% as Stock Approaches Key Support LevelGap Up Stocks - dars.gov.et
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX) - AOL.com
Orthofix Medical | 4: Statement of changes in beneficial ownership of securities-Director Hannon Jason - Moomoo
Enterprise value to EBIT forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Enterprise value to EBITDA forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? - aol.com
Price to sales forward of Orthofix Medical Inc. – BOATS:OFIX - TradingView
Orthofix Medical (OFIX) Receives a Buy from Barrington - The Globe and Mail
Price to book forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Orthofix Medical | 8-K: Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidancemoomoo - Moomoo
Orthofix Medical Shares Rise After Medicare Billing for Bone Growth Stimulators Expected to Return to Prior Rates - Moomoo
Orthofix Medical (OFIX) Soars 16% Following CMS Reversal on Bone Growth Stimulators - GuruFocus
Canaccord reiterates Orthofix Medical stock rating after CMS reversal - Investing.com
Canaccord reiterates Orthofix Medical stock rating after CMS reversal By Investing.com - Investing.com Nigeria
Orthofix Medical Is Maintained at Outperform by Barrington Research - Moomoo
Why is Orthofix Medical stock surging today? By Investing.com - Investing.com Canada
Orthofix Medical stock surges on Medicare reimbursement reversal By Investing.com - Investing.com Australia
Orthofix Medical stock surges on Medicare reimbursement reversal - Investing.com
Orthofix (OFIX) Adjusts Expectations After Medicare Guidance Cha - GuruFocus
Orthofix Medical Inc. (OFIX) Sees 6.7% Pre-Market Increase - GuruFocus
Enterprise value to revenue forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Orthofix Medical rises on CMS reversal of non-invasive bone growth stimulators - MSN
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix - TMX Newsfile
Orthofix Medical Sees Medicare Reimbursement Policy Restored - The Globe and Mail
Orthofix Medical (OFIX) Among the Best Small-Cap Growth Stocks To Buy Now - Yahoo Finance
Orthofix Medical (OFIX) Surges 10% After CMS Reversal on Bone Gr - GuruFocus
Orthofix (OFIX) expects Medicare bone stimulator reimbursement to return to prior levels - Stock Titan
Orthofix (OFIX) moves 5.1% higher: Will this strength last? - MSN
Orthofix (OFIX) Moves 5.1% Higher: Will This Strength Last? - Yahoo Finance
Why (OFIX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Orthofix Medical Inc (OFIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Orthofix Medical Inc 주식 (OFIX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| HENNEMAN JOHN B III | Director |
May 07 '26 |
Buy |
12.26 |
5,000 |
61,295 |
90,809 |
| Engine Capital Management, LP | 10% Owner |
May 05 '26 |
Buy |
11.99 |
112,950 |
1,354,587 |
3,783,131 |
| Engine Capital Management, LP | 10% Owner |
May 06 '26 |
Buy |
12.23 |
41,946 |
512,916 |
3,821,285 |
| Engine Capital Management, LP | 10% Owner |
May 07 '26 |
Buy |
12.18 |
30,000 |
365,425 |
3,848,573 |
| Cedron Jorge Andres | CLO |
Apr 16 '26 |
Sale |
12.82 |
3,743 |
47,985 |
59,006 |
| Vitale Lucas | CP&BOO |
Mar 17 '26 |
Sale |
11.92 |
4,269 |
50,886 |
160,449 |
| CAPPS VICKIE L | Director |
Mar 09 '26 |
Buy |
12.48 |
2,500 |
31,200 |
25,085 |
| CAPPS VICKIE L | Director |
Mar 10 '26 |
Buy |
12.45 |
2,500 |
31,124 |
27,585 |
| Andrews Julie | CFO |
Mar 04 '26 |
Sale |
12.92 |
2,425 |
31,322 |
91,109 |
| Andrews Julie | CFO |
Mar 05 '26 |
Sale |
12.55 |
2,363 |
29,658 |
88,746 |
1.04%
11.95%
자본화:
|
볼륨(24시간):